I'm finding the same exact reaction in medtech. Same foreboding myths, same massive opportunities, and same chance to build lean operations. We're grinding along but I'm surprised that tractable obstacles look scary to otherwise savvy investors.
Have you looked into government grants? It's a very different process and set of expectations than a pitch deck, but the capital is non-dilutionary and there is a bunch of stimulus money sloshing around. Obama seems to recognize that the future US economy will be in biotech and greentech.
Really? I've always found the number one barrier in medtech to be fact that the feds won't let you unleash cutting edge new medtech on humanity without a crushing time and money penalty to prove it is safe and worth it.
Just so people don't miss interpret what I'm saying: I do think we should try to prove medtech is safe and does something. But I think the quantity of proof we require slows down innovation tremendously. And the penalty we pay for bringing things YEARS to market later then we could have is human lives.
Have you looked into government grants? It's a very different process and set of expectations than a pitch deck, but the capital is non-dilutionary and there is a bunch of stimulus money sloshing around. Obama seems to recognize that the future US economy will be in biotech and greentech.